N~2~-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-sulfonyl)-N-[(2-methoxyphenyl)methyl]-N~2~-methylglycinamide
Chemical Structure Depiction of
N~2~-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-sulfonyl)-N-[(2-methoxyphenyl)methyl]-N~2~-methylglycinamide
N~2~-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-sulfonyl)-N-[(2-methoxyphenyl)methyl]-N~2~-methylglycinamide
Compound characteristics
Compound ID: | E197-1092 |
Compound Name: | N~2~-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-sulfonyl)-N-[(2-methoxyphenyl)methyl]-N~2~-methylglycinamide |
Molecular Weight: | 446.48 |
Molecular Formula: | C20 H22 N4 O6 S |
Smiles: | CN(CC(NCc1ccccc1OC)=O)S(c1ccc2c(c1)C(NCC(N2)=O)=O)(=O)=O |
Stereo: | ACHIRAL |
logP: | 1.2813 |
logD: | 0.7481 |
logSw: | -2.6826 |
Hydrogen bond acceptors count: | 12 |
Hydrogen bond donors count: | 3 |
Polar surface area: | 115.068 |
InChI Key: | URCFJUOKJYUZCG-UHFFFAOYSA-N |